1. Home
  2. ONC vs TRGP Comparison

ONC vs TRGP Comparison

Compare ONC & TRGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • TRGP
  • Stock Information
  • Founded
  • ONC 2010
  • TRGP 2005
  • Country
  • ONC Switzerland
  • TRGP United States
  • Employees
  • ONC N/A
  • TRGP N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • TRGP Natural Gas Distribution
  • Sector
  • ONC Health Care
  • TRGP Utilities
  • Exchange
  • ONC Nasdaq
  • TRGP Nasdaq
  • Market Cap
  • ONC 37.3B
  • TRGP 36.1B
  • IPO Year
  • ONC N/A
  • TRGP 2010
  • Fundamental
  • Price
  • ONC $342.50
  • TRGP $162.05
  • Analyst Decision
  • ONC Strong Buy
  • TRGP Strong Buy
  • Analyst Count
  • ONC 10
  • TRGP 17
  • Target Price
  • ONC $340.70
  • TRGP $206.65
  • AVG Volume (30 Days)
  • ONC 297.4K
  • TRGP 1.5M
  • Earning Date
  • ONC 11-11-2025
  • TRGP 11-04-2025
  • Dividend Yield
  • ONC N/A
  • TRGP 2.46%
  • EPS Growth
  • ONC N/A
  • TRGP 46.70
  • EPS
  • ONC N/A
  • TRGP 6.97
  • Revenue
  • ONC $4,562,002,000.00
  • TRGP $17,078,700,000.00
  • Revenue This Year
  • ONC $896.81
  • TRGP $21.14
  • Revenue Next Year
  • ONC N/A
  • TRGP $21.02
  • P/E Ratio
  • ONC N/A
  • TRGP $23.28
  • Revenue Growth
  • ONC 47.33
  • TRGP 5.03
  • 52 Week Low
  • ONC $170.99
  • TRGP $150.00
  • 52 Week High
  • ONC $355.30
  • TRGP $218.51
  • Technical
  • Relative Strength Index (RSI)
  • ONC 57.00
  • TRGP 42.88
  • Support Level
  • ONC $334.53
  • TRGP $169.78
  • Resistance Level
  • ONC $355.30
  • TRGP $175.78
  • Average True Range (ATR)
  • ONC 7.30
  • TRGP 5.17
  • MACD
  • ONC 0.00
  • TRGP -0.78
  • Stochastic Oscillator
  • ONC 61.75
  • TRGP 8.46

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

About TRGP Targa Resources Inc.

Targa Resources is a midstream firm that primarily operates gathering and processing assets with substantial positions in the Permian, Stack, Scoop, and Bakken plays. It has fractionation capacity at Mont Belvieu and operates a liquefied petroleum gas export terminal. The Grand Prix natural gas liquids pipeline is another important asset.

Share on Social Networks: